(("metabolic disorders" OR "metabolic complications") AND hiv) AND ((clinical[Title/Abstract] AND trial[Title/Abstract]) OR clinical trials[MeSH Terms] OR clinical trial[Publication Type] OR random*[Title/Abstract] OR random allocation[MeSH Terms] OR therapeutic use[MeSH Subheading])

Metabolic complications of HIV treatment; HIV-related lipodystrophy.

Bouvier G.

HIV Clin. 2000 Fall;12(4):14-5. No abstract available.

PMID: 18841627 [PubMed - indexed for MEDLINE]

Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: a randomized controlled trial.

Lo J, You SM, Canavan B, Liebau J, Beltrani G, Koutkia P, Hemphill L, Lee H, Grinspoon S.

JAMA. 2008 Aug 6;300(5):509-19.

PMID: 18677023 [PubMed - indexed for MEDLINE]

Genetic analysis implicates resistin in HIV lipodystrophy.

Ranade K, Geese WJ, Noor M, Flint O, Tebas P, Mulligan K, Powderly W, Grinspoon SK, Dube MP.

AIDS. 2008 Aug 20;22(13):1561-8.

PMID: 18670214 [PubMed - indexed for MEDLINE]

Influenza guideline for South Africa--update 2008.

Green RJ, Feldman C, Schoub B, Richards GA, Madhi SA, Zar HJ, Lalloo U; Guideline Committee of 1999, Klugman K, Phillips D, Cameron NA, Eggers RR.

S Afr Med J. 2008 Mar;98(3 Pt 2):224-30. Review.

PMID: 18652399 [PubMed - indexed for MEDLINE]

Managing long-term complications of HIV infection.

Kirton CA.

Nursing. 2008 Aug;38(8):44-50; quiz 50-1. Review.

PMID: 18648302 [PubMed - indexed for MEDLINE]

Simple anthropometric measures correlate with metabolic risk indicators as strongly as magnetic resonance imaging-measured adipose tissue depots in both HIV-infected and control subjects.

Scherzer R, Shen W, Bacchetti P, Kotler D, Lewis CE, Shlipak MG, Heymsfield SB, Grunfeld C; Study of Fat Redistribution Metabolic Change in HIV Infection (FRAM).

Am J Clin Nutr. 2008 Jun;87(6):1809-17.

PMID: 18541572 [PubMed - indexed for MEDLINE]

Use of diet, nutritional supplements and exercise in HIV-infected patients receiving combination antiretroviral therapies: a systematic review.

Leyes P, Martínez E, Forga Mde T.

Antivir Ther. 2008;13(2):149-59. Review.

PMID: 18505167 [PubMed - indexed for MEDLINE]

Report from the 14th Retrovirus Conference. Metabolic complications: lipoatrophy, lipohypertrophy, and cardiovascular risk.

Currier J.

AIDS Clin Care. 2007 May;19(5):40-1. No abstract available.

PMID: 18398989 [PubMed - indexed for MEDLINE]

Metabolic complications of antiretroviral therapy in HIV-infected children.

Eley B.

Expert Opin Drug Metab Toxicol. 2008 Jan;4(1):37-49. Review.

PMID: 18370857 [PubMed - indexed for MEDLINE]

10:

[Difficult contraceptions]

Bricaire C, Plu-Bureau G.

Rev Prat. 2008 Jan 15;58(1):55-64. Review. French.

PMID: 18326363 [PubMed - indexed for MEDLINE]

11:

6. Secondary immunodeficiencies, including HIV infection.

Chinen J, Shearer WT.

J Allergy Clin Immunol. 2008 Feb;121(2 Suppl):S388-92; quiz S417. Review.

PMID: 18241688 [PubMed - indexed for MEDLINE]

12:

HIV lipodystrophy and its metabolic consequences: implications for clinical practice.

Wierzbicki AS, Purdon SD, Hardman TC, Kulasegaram R, Peters BS.

Curr Med Res Opin. 2008 Mar;24(3):609-24. Review.

PMID: 18208641 [PubMed - indexed for MEDLINE]

13:

Antiretroviral therapy-associated toxicities in the resource-poor world: the challenge of a limited formulary.

Murphy RA, Sunpath H, Kuritzkes DR, Venter F, Gandhi RT.

J Infect Dis. 2007 Dec 1;196 Suppl 3:S449-56. Review.

PMID: 18181693 [PubMed - indexed for MEDLINE]

14:

Reduced adipogenic gene expression in thigh adipose tissue precedes human immunodeficiency virus-associated lipoatrophy.

Kratz M, Purnell JQ, Breen PA, Thomas KK, Utzschneider KM, Carr DB, Kahn SE, Hughes JP, Rutledge EA, Van Yserloo B, Yukawa M, Weigle DS.

J Clin Endocrinol Metab. 2008 Mar;93(3):959-66. Epub 2007 Dec 18.

PMID: 18089690 [PubMed - indexed for MEDLINE]

15:

Drug discovery and development with plant-derived compounds.

Potterat O, Hamburger M.

Prog Drug Res. 2008;65:45, 47-118. Review.

PMID: 18084913 [PubMed - indexed for MEDLINE]

16:

Metabolic consequences and therapeutic options in highly active antiretroviral therapy in human immunodeficiency virus-1 infection.

Samaras K.

J Antimicrob Chemother. 2008 Feb;61(2):238-45. Epub 2007 Dec 10. Review.

PMID: 18070830 [PubMed - indexed for MEDLINE]

17:

HIV treatment series. Metabolic complications myths. Some misunderstandings about treatment.

Wohl DA.

Posit Aware. 2007 Nov-Dec;18(6):25-8. No abstract available.

PMID: 18069150 [PubMed - indexed for MEDLINE]

18:

Osteonecrosis in patients with human immunodeficiency virus type 1 infection in Taiwan.

Ho YC, Shih TT, Lin YH, Hsiao CF, Chen MY, Hsieh SM, Sheng WH, Sun HY, Hung CC, Chang SC.

Jpn J Infect Dis. 2007 Nov;60(6):382-6.

PMID: 18032839 [PubMed - indexed for MEDLINE]

19:

Toxicogenetics of antiretroviral therapy: genetic factors that contribute to metabolic complications.

Tarr PE, Telenti A.

Antivir Ther. 2007;12(7):999-1013. Review.

PMID: 18018758 [PubMed - indexed for MEDLINE]

20:

HIV and HIV treatment: effects on fats, glucose and lipids.

Gkrania-Klotsas E, Klotsas AE.

Br Med Bull. 2007;84:49-68. Epub 2007 Nov 2. Review.

PMID: 17981955 [PubMed - indexed for MEDLINE]

Recent Activity